{"id":88,"date":"2015-03-05T17:46:36","date_gmt":"2015-03-05T17:46:36","guid":{"rendered":""},"modified":"2017-06-27T13:55:54","modified_gmt":"2017-06-27T13:55:54","slug":"xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne","status":"publish","type":"post","link":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/","title":{"rendered":"Xarelto Lawsuit News: Bayer and Johnson &#038; Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com"},"content":{"rendered":"<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;font-size: 14px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\"><span itemprop=\"geo\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/address\"><span itemprop=\"addressLocality\">PHILADELPHIA<\/span><\/span><\/span>, <span class=\"xn-chron\">Feb. 25, 2015<\/span> \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Bayer and Johnson &amp; Johnson was made stating that they will pursue additional FDA approvals for Xarelto, their blood thinner drug, despite the fact that lawsuits against them have been consolidated into multidistrict litigation in two U.S. courts. According to Drug Watch, the announcement was made last month by Bayer and J&amp;J, and they seek further federal approvals for Xarelto for stroke patients. <span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px;\"><\/span> <\/span> <\/span><\/p>\n<p itemprop=\"articleBody\" style=\"margin: 0px; line-height: 1.333em; padding: 0px 0px 10px; color: #464646; font-size: 12px;\">&nbsp;<\/p>\n<p> <\/p>\n<p>The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in Pennsylvania and Louisiana consolidated cases into multidistrict litigation (MDL) as well as a mass tort program. Over 100 filed lawsuits, with claims of serious health problems and even death as a result of using Xarelto, are now awaiting trial.<\/p>\n<p>Chris Janish, CEO of MTS commented on the recent news regarding Bayer and Johnson &amp; Johnson, \"The recent FDA request is one that will be watched carefully by legal experts, especially in light of the fact that Xarelto lawsuit filings continue to rise each month. The blood thinner drug has showed promising results, however, the lawsuit claims being filed will determine at what cost. What the FDA has to say about the new approval request may determine an important direction in the Xarelto mass tort litigation.\"<\/p>\n<p>MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: https:\/\/www.lawsuitsettlementnews.com\/pradaxa-all-blood-thinner-cases<\/p>\n<p>If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: https:\/\/www.lawsuitsettlementnews.com\/about-our-products-and-services<\/p>\n<p>If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.<\/p>\n<p>Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: https:\/\/www.lawsuitsettlementnews.com\/terms-of-service<\/p>\n<p>&nbsp;<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">Contact: Chris Janish, CEO<br \/>Ph. 877.571.0405<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">SOURCE MT Services LLC<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">RELATED LINKS<br \/>https:\/\/www.lawsuitsettlementnews.com<br \/>More by this Source<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">&nbsp;<\/p>\n<div style=\"position: absolute; left: -40px; top: -25px; width: 1px; height: 1px; overflow: hidden;\" data-mce-bogus=\"1\" class=\"mcePaste\" id=\"_mcePaste\"><a name=\"linktopagetop\"><\/a><\/p>\n<p itemprop=\"articleBody\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\"><span itemprop=\"geo\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/address\"><span itemprop=\"addressLocality\">BOCA RATON, Fla.<\/span><\/span> <\/span>, <span class=\"xn-chron\">Jan. 22, 2015<\/span> \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting potential plaintiffs who have dealt with complications as a result of GranuFlo, Xarelto, and\/or Morcellator products.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;font-size: 14px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\"><span itemprop=\"geo\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/address\"><span itemprop=\"addressLocality\">PHILADELPHIA<\/span><\/span><\/span>, <span class=\"xn-chron\">Feb. 25, 2015<\/span> \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Bayer and Johnson &amp; Johnson was made stating that they will pursue additional FDA approvals for Xarelto, their blood thinner drug, despite the fact that lawsuits against them have been consolidated into multidistrict litigation in two U.S. courts. According to Drug Watch, the announcement was made last month by Bayer and J&amp;J, and they seek further federal approvals for Xarelto for stroke patients. <span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px;\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\" style=\"line-height: 19.6000003814697px; margin: 0px;\"><\/span> <\/span> <\/span><\/p>\n<p itemprop=\"articleBody\" style=\"margin: 0px; line-height: 1.333em; padding: 0px 0px 10px; color: #464646; font-size: 12px;\">&nbsp;<\/p>\n<p> <\/p>\n<p>The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in Pennsylvania and Louisiana consolidated cases into multidistrict litigation (MDL) as well as a mass tort program. Over 100 filed lawsuits, with claims of serious health problems and even death as a result of using Xarelto, are now awaiting trial.<\/p>\n<p>Chris Janish, CEO of MTS commented on the recent news regarding Bayer and Johnson &amp; Johnson, \"The recent FDA request is one that will be watched carefully by legal experts, especially in light of the fact that Xarelto lawsuit filings continue torise each month. The blood thinner drug has showed promising results, however, the lawsuit claims being filed will determine at what cost. What the FDA has to say about the new approval request may determine an important direction in the Xarelto mass tort litigation.\"<\/p>\n<p>MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: https:\/\/www.lawsuitsettlementnews.com\/pradaxa-all-blood-thinner-cases<\/p>\n<p>If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: https:\/\/www.lawsuitsettlementnews.com\/about-our-products-and-services<\/p>\n<p>If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.<\/p>\n<p>Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: https:\/\/www.lawsuitsettlementnews.com\/terms-of-service<\/p>\n<p>&nbsp;<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">Contact: Chris Janish, CEO<br \/>Ph. 877.571.0405<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">SOURCE MT Services LLC<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">RELATED LINKS<br \/>https:\/\/www.lawsuitsettlementnews.com<br \/>More by this Source<\/p>\n<p itemprop=\"articleBody\" style=\"line-height: 19.6000003814697px; margin: 0px 0px 10px; color: #404040; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;\">&nbsp;<\/p>\n<div style=\"position: absolute; left: -40px; top: -25px; width: 1px; height: 1px; overflow: hidden;\" data-mce-bogus=\"1\" class=\"mcePaste\" id=\"_mcePaste\"><a name=\"linktopagetop\"><\/a><\/p>\n<p itemprop=\"articleBody\"><span class=\"xn-location\" itemprop=\"contentLocation\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/Place\"><span itemprop=\"geo\" itemscope=\"\" itemtype=\"http:\/\/schema.org\/address\"><span itemprop=\"addressLocality\">BOCA RATON, Fla.<\/span><\/span> <\/span>, <span class=\"xn-chron\">Jan. 22, 2015<\/span> \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting potential plaintiffs who have dealt with complications as a result of GranuFlo, Xarelto, and\/or Morcellator products.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Xarelto Lawsuit News: Bayer and Johnson &amp; Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xarelto Lawsuit News: Bayer and Johnson &amp; Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Feb. 25, 2015 \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Bayer and Johnson &amp; Johnson was made stating that they will pursue additional FDA approvals for Xarelto, their blood thinner drug, despite the fact that lawsuits against them have been consolidated into multidistrict litigation in two U.S. courts. According to Drug Watch, the announcement was made last month by Bayer and J&amp;J, and they seek further federal approvals for Xarelto for stroke patients.   &nbsp;   The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in Pennsylvania and Louisiana consolidated cases into multidistrict litigation (MDL) as well as a mass tort program. Over 100 filed lawsuits, with claims of serious health problems and even death as a result of using Xarelto, are now awaiting trial. Chris Janish, CEO of MTS commented on the recent news regarding Bayer and Johnson &amp; Johnson, &quot;The recent FDA request is one that will be watched carefully by legal experts, especially in light of the fact that Xarelto lawsuit filings continue torise each month. The blood thinner drug has showed promising results, however, the lawsuit claims being filed will determine at what cost. What the FDA has to say about the new approval request may determine an important direction in the Xarelto mass tort litigation.&quot; MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS&#039; services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: https:\/\/www.lawsuitsettlementnews.com\/pradaxa-all-blood-thinner-cases If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: https:\/\/www.lawsuitsettlementnews.com\/about-our-products-and-services If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly. Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer&#039;s request. For a list of full disclosures please visit the company&#039;s website disclosure page at: https:\/\/www.lawsuitsettlementnews.com\/terms-of-service &nbsp; Contact: Chris Janish, CEOPh. 877.571.0405 SOURCE MT Services LLC RELATED LINKShttps:\/\/www.lawsuitsettlementnews.comMore by this Source &nbsp;  BOCA RATON, Fla. , Jan. 22, 2015 \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting potential plaintiffs who have dealt with complications as a result of GranuFlo, Xarelto, and\/or Morcellator products.  &nbsp;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/\" \/>\n<meta property=\"og:site_name\" content=\"Lawsuit Settlement News\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-05T17:46:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-06-27T13:55:54+00:00\" \/>\n<meta name=\"author\" content=\"Lawsuit Settlement News\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lawsuit Settlement News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#website\",\"url\":\"https:\/\/www.lawsuitsettlementnews.com\/\",\"name\":\"Lawsuit Settlement News\",\"description\":\"Mass Tort Services LLC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lawsuitsettlementnews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/\",\"url\":\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/\",\"name\":\"Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News\",\"isPartOf\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#website\"},\"datePublished\":\"2015-03-05T17:46:36+00:00\",\"dateModified\":\"2017-06-27T13:55:54+00:00\",\"author\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/67f9ff7852c0df07b272052cb8b30a9b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lawsuitsettlementnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xarelto Lawsuit News: Bayer and Johnson &#038; Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/67f9ff7852c0df07b272052cb8b30a9b\",\"name\":\"Lawsuit Settlement News\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/73380f98967f6bd20605b0ea38eb5e4d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/73380f98967f6bd20605b0ea38eb5e4d?s=96&d=mm&r=g\",\"caption\":\"Lawsuit Settlement News\"},\"url\":\"https:\/\/www.lawsuitsettlementnews.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/","og_locale":"en_US","og_type":"article","og_title":"Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News","og_description":"PHILADELPHIA, Feb. 25, 2015 \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Bayer and Johnson &amp; Johnson was made stating that they will pursue additional FDA approvals for Xarelto, their blood thinner drug, despite the fact that lawsuits against them have been consolidated into multidistrict litigation in two U.S. courts. According to Drug Watch, the announcement was made last month by Bayer and J&amp;J, and they seek further federal approvals for Xarelto for stroke patients.   &nbsp;   The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in Pennsylvania and Louisiana consolidated cases into multidistrict litigation (MDL) as well as a mass tort program. Over 100 filed lawsuits, with claims of serious health problems and even death as a result of using Xarelto, are now awaiting trial. Chris Janish, CEO of MTS commented on the recent news regarding Bayer and Johnson &amp; Johnson, \"The recent FDA request is one that will be watched carefully by legal experts, especially in light of the fact that Xarelto lawsuit filings continue torise each month. The blood thinner drug has showed promising results, however, the lawsuit claims being filed will determine at what cost. What the FDA has to say about the new approval request may determine an important direction in the Xarelto mass tort litigation.\" MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: https:\/\/www.lawsuitsettlementnews.com\/pradaxa-all-blood-thinner-cases If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: https:\/\/www.lawsuitsettlementnews.com\/about-our-products-and-services If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly. Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: https:\/\/www.lawsuitsettlementnews.com\/terms-of-service &nbsp; Contact: Chris Janish, CEOPh. 877.571.0405 SOURCE MT Services LLC RELATED LINKShttps:\/\/www.lawsuitsettlementnews.comMore by this Source &nbsp;  BOCA RATON, Fla. , Jan. 22, 2015 \/PRNewswire\/ --&nbsp;MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting potential plaintiffs who have dealt with complications as a result of GranuFlo, Xarelto, and\/or Morcellator products.  &nbsp;","og_url":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/","og_site_name":"Lawsuit Settlement News","article_published_time":"2015-03-05T17:46:36+00:00","article_modified_time":"2017-06-27T13:55:54+00:00","author":"Lawsuit Settlement News","twitter_card":"summary","twitter_misc":{"Written by":"Lawsuit Settlement News","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.lawsuitsettlementnews.com\/#website","url":"https:\/\/www.lawsuitsettlementnews.com\/","name":"Lawsuit Settlement News","description":"Mass Tort Services LLC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lawsuitsettlementnews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/","url":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/","name":"Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com - Lawsuit Settlement News","isPartOf":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/#website"},"datePublished":"2015-03-05T17:46:36+00:00","dateModified":"2017-06-27T13:55:54+00:00","author":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/67f9ff7852c0df07b272052cb8b30a9b"},"breadcrumb":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lawsuitsettlementnews.com\/xarelto-lawsuit-news-bayer-and-johnson-johnson-pursue-additional-fda-approvals-for-xarelto-while-cases-against-the-blood-thinner-are-consolidated-into-multidistrict-litigation-says-lawsuitsettlementne\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lawsuitsettlementnews.com\/"},{"@type":"ListItem","position":2,"name":"Xarelto Lawsuit News: Bayer and Johnson &#038; Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com"}]},{"@type":"Person","@id":"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/67f9ff7852c0df07b272052cb8b30a9b","name":"Lawsuit Settlement News","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lawsuitsettlementnews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/73380f98967f6bd20605b0ea38eb5e4d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/73380f98967f6bd20605b0ea38eb5e4d?s=96&d=mm&r=g","caption":"Lawsuit Settlement News"},"url":"https:\/\/www.lawsuitsettlementnews.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/posts\/88"}],"collection":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/comments?post=88"}],"version-history":[{"count":0,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/posts\/88\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/media?parent=88"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/categories?post=88"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/tags?post=88"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}